Timothy Donahue

Timothy R Donahue

Professor, Surgery, University of California Los Angeles

Professor, Molecular and Medical Pharmacology, University of California Los Angeles

(310) 825-9427

Mailing Address:
UCLA Surg-Surg Onc
BOX 956904
72-215
Los Angeles, CA 90095

Office Address:
10833 Le Conte Ave.
72-256 CHS
Los Angeles, CA 90095

Fax Number:
(310) 206-2472

Office Phone Number:
(310) 206-7440

Work Phone Number:
(310) 794-7788

Affiliations

Member, CTSI, I3T Theme, Immunity, Microbes & Molecular Pathogenesis GPB Home Area, JCCC Cancer and Stem Cell Biology Program Area, Molecular Pharmacology GPB Home Area
 

Biography

Dr. Timothy Donahue is a Professor of Surgery at the David Geffen School of Medicine at UCLA. He also serves as the Chief of the Division of Surgical Oncology, and Vice Chair for Clinical Cancer Care. Dr. Donahue oversees the UCLA pancreatic cancer program which is one of the largest in the nation. He also has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program.

Dr. Donahue is a very busy pancreatic surgeon. He performs three to four pancreatic surgeries per week. He is genuinely interested in caring for patients with pancreatic cancer. His clinical research is focused on improving the care of patients with borderline resectable or locally advanced disease. Dr. Donahue is a strong advocate of prolonged preoperative chemo- or radiation therapy for this group of patients to optimally select for those who will benefit from a surgical resection. As a result of this approach, Dr. Donahue and his team have among the best reported survival rates reported in the world.

In addition to his clinical work, Dr. Donahue is the Principal Investigator of a National Institutes of Health funded research laboratory. His scientific research focuses on developing improved treatment strategies and earlier diagnostic markers for patients with pancreatic cancer. He collaborates closely with other scientists across the UCLA campus, including faculty in the Ahmanson Translational Imaging Division and California Nanosystems Institute. He is optimistic that therapy for pancreatic cancer will markedly improve during his career.

After graduating from college and medical school at Northwestern University, Dr. Donahue completed his surgical and research training at UCLA. He has been on the faculty and in his current role since 2009. He resides in the Pacific Palisades with his wife and three children.

Publications